-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Innovations in Hemophilia Research: Fitusiran, An Investigational Rebalancing Agent for the Treatment of Hemophilia

Sponsor: Sanofi
Program: Industry Theaters
Hematology Disease Topics & Pathways:
Treatment Considerations, Non-Biological therapies
Sunday, December 8, 2024: 11:30 AM-12:30 PM
Room 5A (San Diego Convention Center)
Speakers:
Craig Benson, MD, Sanofi , Marek Demissie, MD, PhD, Sanofi and Marja Puurunen, MD, PhD, Sanofi
Disclosures:
No relevant conflicts of interest to declare.

For in-person participants only
See more of: Industry Theaters
<< Previous Session | Next Session >>